198 related articles for article (PubMed ID: 27501187)
1. Standard PK/PD concepts can be applied to determine a dosage regimen for a macrolide: the case of tulathromycin in the calf.
Toutain PL; Potter T; Pelligand L; Lacroix M; Illambas J; Lees P
J Vet Pharmacol Ther; 2017 Jan; 40(1):16-27. PubMed ID: 27501187
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetic/pharmacodynamic integration and modelling of amoxicillin for the calf pathogens Mannheimia haemolytica and Pasteurella multocida.
Lees P; Pelligand L; Illambas J; Potter T; Lacroix M; Rycroft A; Toutain PL
J Vet Pharmacol Ther; 2015 Oct; 38(5):457-70. PubMed ID: 25669418
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic-pharmacodynamic integration and modelling of oxytetracycline for the calf pathogens Mannheimia haemolytica and Pasteurella multocida.
Lees P; Potter T; Pelligand L; Toutain PL
J Vet Pharmacol Ther; 2018 Feb; 41(1):28-38. PubMed ID: 28736817
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic-pharmacodynamic integration and modelling of florfenicol in calves.
Sidhu P; Rassouli A; Illambas J; Potter T; Pelligand L; Rycroft A; Lees P
J Vet Pharmacol Ther; 2014 Jun; 37(3):231-42. PubMed ID: 24341543
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetic/Pharmacodynamic Modeling of Tulathromycin against
Zhou Q; Zhang G; Wang Q; Liu W; Huang Y; Yu P; Li Y; Ding H; Fang B
Front Pharmacol; 2017; 8():392. PubMed ID: 28701951
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic-pharmacodynamic integration and modelling of oxytetracycline administered alone and in combination with carprofen in calves.
Brentnall C; Cheng Z; McKellar QA; Lees P
Res Vet Sci; 2013 Jun; 94(3):687-94. PubMed ID: 23415880
[TBL] [Abstract][Full Text] [Related]
7. Pneumatic dart delivery of tulathromycin in calves results in lower antimicrobial concentrations and increased biomarkers of stress and injection site inflammation compared with subcutaneous injection.
Coetzee JF; Kleinhenz MD; Magstadt DR; Cooper VL; Wulf LW; Van Engen NK; Smith JS; Rand N; KuKanich B; Gorden PJ
J Anim Sci; 2018 Jul; 96(8):3089-3101. PubMed ID: 29873747
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of tulathromycin in the treatment of bovine respiratory disease associated with induced Mycoplasma bovis infections in young dairy calves.
Godinho KS; Rae A; Windsor GD; Tilt N; Rowan TG; Sunderland SJ
Vet Ther; 2005; 6(2):96-112. PubMed ID: 16094558
[TBL] [Abstract][Full Text] [Related]
9. A large potentiation effect of serum on the in vitro potency of tulathromycin against Mannheimia haemolytica and Pasteurella multocida.
Lees P; Illambas J; Potter TJ; Pelligand L; Rycroft A; Toutain PL
J Vet Pharmacol Ther; 2017 Oct; 40(5):419-428. PubMed ID: 27891615
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetic and pharmacodynamic integration and modelling of marbofloxacin in calves for Mannheimia haemolytica and Pasteurella multocida.
Potter T; Illambas J; Pelligand L; Rycroft A; Lees P
Vet J; 2013 Jan; 195(1):53-8. PubMed ID: 23084327
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of tulathromycin in the treatment and prevention of natural outbreaks of bovine respiratory disease in European cattle.
Godinho KS; Wolf RM; Sherington J; Rowan TG; Sunderland SJ; Evans NA
Vet Ther; 2005; 6(2):122-35. PubMed ID: 16094560
[TBL] [Abstract][Full Text] [Related]
12. Impact of bovine respiratory disease on the pharmacokinetics of danofloxacin and tulathromycin in different ages of calves.
Mzyk DA; Bublitz CM; Martinez MN; Davis JL; Baynes RE; Smith GW
PLoS One; 2019; 14(6):e0218864. PubMed ID: 31233558
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic efficacy of tulathromycin, a novel triamilide antimicrobial, against bovine respiratory disease in feeder calves.
Kilgore WR; Spensley MS; Sun F; Nutsch RG; Rooney KA; Skogerboe TL
Vet Ther; 2005; 6(2):143-53. PubMed ID: 16094562
[TBL] [Abstract][Full Text] [Related]
14. Pharmacodynamics of marbofloxacin for calf pneumonia pathogens.
Illambas J; Potter T; Cheng Z; Rycroft A; Fishwick J; Lees P
Res Vet Sci; 2013 Jun; 94(3):675-81. PubMed ID: 23375665
[TBL] [Abstract][Full Text] [Related]
15. Estimation of tulathromycin depletion in plasma and milk after subcutaneous injection in lactating goats using a nonlinear mixed-effects pharmacokinetic modeling approach.
Lin Z; Cuneo M; Rowe JD; Li M; Tell LA; Allison S; Carlson J; Riviere JE; Gehring R
BMC Vet Res; 2016 Nov; 12(1):258. PubMed ID: 27863483
[TBL] [Abstract][Full Text] [Related]
16. Comparative efficacy of tulathromycin, tilmicosin, and florfenicol in the treatment of bovine respiratory disease in stocker cattle.
Nutsch RG; Skogerboe TL; Rooney KA; Weigel DJ; Gajewski K; Lechtenberg KF
Vet Ther; 2005; 6(2):167-79. PubMed ID: 16094564
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of tulathromycin following subcutaneous administration in meat goats.
Young G; Smith GW; Leavens TL; Wetzlich SE; Baynes RE; Mason SE; Riviere JE; Tell LA
Res Vet Sci; 2011 Jun; 90(3):477-9. PubMed ID: 20638089
[TBL] [Abstract][Full Text] [Related]
18. Clinical effectiveness of tulathromycin, a novel triamilide antimicrobial, for the control of respiratory disease in cattle at high risk for developing bovine respiratory disease.
Kilgore WR; Spensley MS; Sun F; Nutsch RG; Rooney KA; Skogerboe TL
Vet Ther; 2005; 6(2):136-42. PubMed ID: 16094561
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of tulathromycin after single and multiple subcutaneous injections in domestic goats (Capra aegagrus hircus).
Clothier KA; Leavens T; Griffith RW; Wetzlich SE; Baynes RE; Riviere JE; Tell LA
J Vet Pharmacol Ther; 2011 Oct; 34(5):448-54. PubMed ID: 21366621
[TBL] [Abstract][Full Text] [Related]
20. Antimicrobial susceptibility patterns and sensitivity to tulathromycin in goat respiratory bacterial isolates.
Clothier KA; Kinyon JM; Griffith RW
Vet Microbiol; 2012 Apr; 156(1-2):178-82. PubMed ID: 22078276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
